chr2-47783515-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001406795.1(MSH6):​c.260+22C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 1,391,608 control chromosomes in the GnomAD database, including 21,647 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.13 ( 1551 hom., cov: 30)
Exomes 𝑓: 0.17 ( 20096 hom. )

Consequence

MSH6
NM_001406795.1 intron

Scores

2

Clinical Significance

Benign reviewed by expert panel U:1B:11

Conservation

PhyloP100: -2.21

Publications

9 publications found
Variant links:
Genes affected
MSH6 (HGNC:7329): (mutS homolog 6) This gene encodes a member of the DNA mismatch repair MutS family. In E. coli, the MutS protein helps in the recognition of mismatched nucleotides prior to their repair. A highly conserved region of approximately 150 aa, called the Walker-A adenine nucleotide binding motif, exists in MutS homologs. The encoded protein heterodimerizes with MSH2 to form a mismatch recognition complex that functions as a bidirectional molecular switch that exchanges ADP and ATP as DNA mismatches are bound and dissociated. Mutations in this gene may be associated with hereditary nonpolyposis colon cancer, colorectal cancer, and endometrial cancer. Transcripts variants encoding different isoforms have been described. [provided by RefSeq, Jul 2013]
MSH6 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • Lynch syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Genomics England PanelApp
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Muir-Torre syndrome
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 2-47783515-C-G is Benign according to our data. Variant chr2-47783515-C-G is described in ClinVar as Benign. ClinVar VariationId is 89295.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.184 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001406795.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH6
NM_000179.3
MANE Select
c.260+22C>G
intron
N/ANP_000170.1
MSH6
NM_001406795.1
c.260+22C>G
intron
N/ANP_001393724.1
MSH6
NM_001406813.1
c.260+22C>G
intron
N/ANP_001393742.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH6
ENST00000234420.11
TSL:1 MANE Select
c.260+22C>G
intron
N/AENSP00000234420.5
MSH6
ENST00000445503.5
TSL:1
n.260+22C>G
intron
N/AENSP00000405294.1
MSH6
ENST00000936511.1
c.260+22C>G
intron
N/AENSP00000606570.1

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19187
AN:
148068
Hom.:
1553
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0551
Gnomad AMI
AF:
0.167
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.157
Gnomad EAS
AF:
0.00103
Gnomad SAS
AF:
0.0614
Gnomad FIN
AF:
0.124
Gnomad MID
AF:
0.193
Gnomad NFE
AF:
0.187
Gnomad OTH
AF:
0.150
GnomAD2 exomes
AF:
0.139
AC:
4248
AN:
30570
AF XY:
0.142
show subpopulations
Gnomad AFR exome
AF:
0.0588
Gnomad AMR exome
AF:
0.120
Gnomad ASJ exome
AF:
0.177
Gnomad EAS exome
AF:
0.000435
Gnomad FIN exome
AF:
0.127
Gnomad NFE exome
AF:
0.206
Gnomad OTH exome
AF:
0.148
GnomAD4 exome
AF:
0.175
AC:
217153
AN:
1243430
Hom.:
20096
Cov.:
33
AF XY:
0.173
AC XY:
103601
AN XY:
600298
show subpopulations
African (AFR)
AF:
0.0432
AC:
1039
AN:
24050
American (AMR)
AF:
0.113
AC:
1672
AN:
14756
Ashkenazi Jewish (ASJ)
AF:
0.163
AC:
2816
AN:
17300
East Asian (EAS)
AF:
0.000378
AC:
11
AN:
29078
South Asian (SAS)
AF:
0.0785
AC:
4394
AN:
55980
European-Finnish (FIN)
AF:
0.122
AC:
5085
AN:
41792
Middle Eastern (MID)
AF:
0.170
AC:
683
AN:
4024
European-Non Finnish (NFE)
AF:
0.192
AC:
193416
AN:
1005430
Other (OTH)
AF:
0.158
AC:
8037
AN:
51020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
8940
17880
26819
35759
44699
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7146
14292
21438
28584
35730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.129
AC:
19185
AN:
148178
Hom.:
1551
Cov.:
30
AF XY:
0.126
AC XY:
9088
AN XY:
72358
show subpopulations
African (AFR)
AF:
0.0552
AC:
2216
AN:
40134
American (AMR)
AF:
0.126
AC:
1884
AN:
15006
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
537
AN:
3430
East Asian (EAS)
AF:
0.00104
AC:
5
AN:
4822
South Asian (SAS)
AF:
0.0614
AC:
283
AN:
4610
European-Finnish (FIN)
AF:
0.124
AC:
1279
AN:
10304
Middle Eastern (MID)
AF:
0.176
AC:
45
AN:
256
European-Non Finnish (NFE)
AF:
0.187
AC:
12491
AN:
66720
Other (OTH)
AF:
0.148
AC:
302
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
817
1633
2450
3266
4083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
212
424
636
848
1060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.140
Hom.:
227
Bravo
AF:
0.127
Asia WGS
AF:
0.0410
AC:
146
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
1
2
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Lynch syndrome (1)
-
-
1
Lynch syndrome 5 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
8.6
DANN
Benign
0.74
PhyloP100
-2.2
PromoterAI
0.018
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55927047; hg19: chr2-48010654; COSMIC: COSV52278035; COSMIC: COSV52278035; API